Hugel Australia recently unveiled BYRYZN Opuluxe V, a professional-use cosmetic formulation designed to elevate skin rejuvenation practices through an advanced blend of Korean skincare innovation and high-performance ingredients.
Formulated in Korea, BYRYZN Opuluxe V features an exclusive 8-in-1 skin-enhancing formulation powered by PLLA (Poly-L-Lactic), PDRN (polydeoxyribonucleotide – trout DNA), postbiotic technology and a curated selection of clinically evaluated ingredients. The formulation is designed to support hydration, elasticity, barrier function, and antioxidant protection to enhance skin vitality.
Key ingredients include:
- PLLA (Poly-L-Lactic Acid) to enhance skin texture and elasticity
- PDRN (Trout DNA) for revitalising skin tone and appearance
- Hyaluronic Acid for maintaining deep hydration and suppleness
- Glutathione to promote a brighter, more even complexion
- Sphingomonas Ferment Extract for barrier support and postbiotic benefit
- Adenosine, Amino Acid Complex, and Vitamin Complex for refined texture, resilience, and skin nourishment.
Designed for use with dermaroller or skin needling devices, BYRYZN Opuluxe V is professionally applied every four weeks across a structured 8-week cosmetic program, delivering 9.9 mL of active formulation to visibly enhance overall skin vitality.
The “Defined by reason. Designed by science.” tagline encapsulates the BYRYZN (by reason) commitment to clinically inspired cosmetic solutions that merge innovation with precision, offering practitioners a robust tool in their skin rejuvenation arsenal.
For more information, contact Hugel Australia at 1800 276 622 or infoaustralia@hugel-aesthetics.com. Follow on Instagram: @byryzn_aesthetics
